May C-peptide index be a new marker to predict proteinuria in anemic patients with type 2 diabetes mellitus?

Bando H, Ebe K, Muneta T, Bando M, Yonei Y. Investigation of fasting ratio of C-peptide/glucose and related markers in diabetes. Archives of Diabetes and Endocrine System 1, 17–24, 2018.10.22259/2638-4981.0101005Search in Google Scholar

Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122, 1122–1127, 2009.10.1016/j.amjmed.2009.04.026279999119958890Search in Google Scholar

Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102–110, 2003.10.2337/diabetes.52.1.10212502499Search in Google Scholar

Chung JO, Park SY, Cho DH, Chung DJ, Chung MY. Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes. Medicine 96, e6586, 2017.10.1097/MD.0000000000006586540308728403090Open DOISearch in Google Scholar

Chung JO, Park SY, Cho DH, Chung DJ, Chung MY. Anemia is inversely associated with serum C-peptide concentrations in individuals with type 2 diabetes. Medicine 97, e11783, 2018.10.1097/MD.0000000000011783613339730095635Open DOISearch in Google Scholar

Gerber PA, Rutter GA. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid Redox Signal 26, 501–518, 2017.2722569010.1089/ars.2016.6755537276727225690Search in Google Scholar

He BB, Xu M, Wei L, Gu YJ, Han JF, Liu YX, Bao YQ, Jia WP. Relationship between anemia and chronic complications in Chinese patients with type 2 diabetes mellitus. Arch Iran Med 18, 277–283, 2015.25959909Search in Google Scholar

Heisler M, Piette JD, Spencer M, Kieffer E, Vijan S. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care 28, 816–822, 2005.10.2337/diacare.28.4.81615793179Open DOISearch in Google Scholar

Hills CE, Brunskill NJ, Squires PE. C-peptide as a therapeutic tool in diabetic nephropathy. Am J Nephrol 31, 389–397, 2010.10.1159/0002898642035743020357430Open DOISearch in Google Scholar

Hosseini MS, Rostami Z, Saadat A, Saadatmand SM, Naeimi E. Anemia and microvascular complications in patients with type 2 diabetes mellitus. Nephrourol Mon 6, e19976, 2014.10.5812/numonthly.19976431771525695026Search in Google Scholar

Inukai T, Matsutomo R, Tayama K, Aso Y, Takemura Y. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus. Exp Clin Endocrinol Diabetes 107, 40–45, 1999.10.1055/s-0029-121207110077354Search in Google Scholar

Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30, 803–817, 2013.10.1111/dme.12159374878823413806Search in Google Scholar

Kim JD, Kang SJ, Lee MK, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Lee WY. C-peptide-based index is more related to incident type 2 diabetes in non-diabetic subjects than insulin-based index. Endocrinol Metab 31, 320–327, 2016.10.3803/EnM.2016.31.2.320492341727349701Open DOISearch in Google Scholar

Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D. Relation of iron stores to oxidative stress in type 2 diabetes. Niger J Clin Pract 16, 100–103, 2013.10.4103/1119-3077.1067762337748123377481Open DOISearch in Google Scholar

Lee EY, Hwang S, Lee SH, Lee YH, Choi AR, Lee Y, Lee BW, Kang ES, Ahn CW, Cha BS, Lee HC. Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes. J Diabetes Investig 5, 517–524, 2014.10.1111/jdi.12187418810925411619Search in Google Scholar

Luppi P, Kallas A, Wahren J. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes? Diabetes Metab Res Rev 29, 357–362, 2013.10.1002/dmrr.240923463541Open DOISearch in Google Scholar

Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 66, 1131–1138, 2004.10.1111/j.1523-1755.2004.00863.x1532740815327408Open DOISearch in Google Scholar

Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, Grassi G, Cavallo-Perin P, Bruno G. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care 32, 301–305, 2009.10.2337/dc08-1241262869719017769Search in Google Scholar

Ranil PK, Raman R, Rachepalli SR, Pal SS, Kulothungan V, Lakshmipathy P, Satagopan U, Kumaramanickavel G, Sharma T. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India 58, 91–94, 2010.Search in Google Scholar

Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 25, 275–278, 2002.10.2337/diacare.25.2.27511815495Open DOISearch in Google Scholar

Saisho Y, Kou K, Tanaka K, Abe T, Shimada A, Kawai T, Itoh H. Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes. Acta Diabetol 50, 987–988, 2013.10.1007/s00592-012-0441-y2321266823212668Open DOISearch in Google Scholar

Saisho Y. Postprandial C-peptide to glucose ratio as a marker of β cell function: implication for the management of type 2 diabetes. Int J Mol Sci 17, E744, 2016.10.3390/ijms17050744488156627196896Open DOISearch in Google Scholar

Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 60, 1258–1265, 2001.1157634010.1046/j.1523-1755.2001.00964.x11576340Search in Google Scholar

Sari R, Balci MK. Relationship between C peptide and chronic complications in type-2 diabetes mellitus. J Natl Med Assoc 97, 1113–1118, 2005.16173326Search in Google Scholar

Sato Y, Endo H, Okuyama H, Takeda T, Iwahashi H, Imagawa A, Yamagata K, Shimomura I, Inoue M. Cellular hypoxia of pancreatic β-cells due to high levels of oxygen consumption for insulin secretion in vitro. J Biol Chem 286, 12524–12532, 2011.10.1074/jbc.M110.194738306945421296882Search in Google Scholar

Sato Y, Inoue M, Yoshizawa T, Yamagata K Moderate hypoxia induces β-cell dysfunction with HIF-1-independent gene expression changes. PLoS One 9, e114868, 2014.10.1371/journal.pone.0114868426476525503986Search in Google Scholar

Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care 23, 339–344, 2000.10.2337/diacare.23.3.33910868862Open DOISearch in Google Scholar

The Diabetes Control and Complications Trial Research Group (The DCCT Research Group). The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44, 968–983, 1995.10.2337/diab.44.8.968Search in Google Scholar

Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care 26, 1164–1169, 2003.10.2337/diacare.26.4.116412663591Open DOISearch in Google Scholar

Thomas MC. Anemia in diabetes: marker or mediator of microvascular disease? Nat Clin Pract Nephrol 3, 20–30, 2007.10.1038/ncpneph037817183259Search in Google Scholar

Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, Pichiri I, Lippi G, Muggeo M, Bonora E. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis 210, 575–580, 2010.10.1016/j.atherosclerosis.2009.12.00820031129Search in Google Scholar